Funded Local Who is raising money in your own backyard?

REDWOOD CITY, Calif. and VANCOUVER, British Columbia, April 25 - EQO Communications, a leading provider of mobile internet phone services, today announced that the company has received a US$9 million Series B financing to fund its global expansion. The financing round was led by Ventures West and included investments from existing investors GrowthWorks and BDC Capital.

Vancouver, BC, March 6, 2007--(T-Net)--Sutus Inc., developer of Business Central, a complete office communications solution designed specifically for small businesses, today announced it closed $5 million in Series A funding from two of Canada’s leading investors, the Working Opportunity Fund, managed by GrowthWorks Capital, and BDC Venture Capital. The proceeds from the funding will be used to fund general company operations, build the sales channel, and initiate manufacturing through general availability of its solution.

Vancouver, BC, February 2, 2007--(T-Net)--Chromos Molecular Systems (TSX: CHR) announced today that it intends to raise approximately $8 million (CDN) through a private placement of Units at a price of $0.15 per Unit. The private placement is being co-led by Dundee Securities Corporation, Canaccord Capital Corporation and Clarus Securities Inc. as agents.

Vancouver, BC, November 16, 2006--(T-Net)--Allon Therapeutics (TSX:NPC), The Neuro Protection Company, today announced it has successfully concluded a first closing of a private placement by issuing 11,250,000 units at a price of $0.80 per unit generating total gross proceeds of $9.0 million. On Wednesday, October 25th, 2006 the Company had announced the launch of an $8.0 million private placement and the company agreed to increase the offering to meet this demand.

From Seattle Post Intelligencer - http://blog.seattlepi.com/venture/archives/103523.asp

Take off to the great white north
Seattle's Madrona Venture Group is venturing north of the border with an investment in PiXPO, a Victoria, B.C.-based company that helps consumers set up online channels to broadcast videos and other personalized digital media.

Madrona's Matt McIlwain -- who is leading the series A deal -- said it is the first investment the firm has made in a British Columbia company in "a long time."

Vancouver, BC, March 22, 2006--Chemokine Therapeutics Corp. (Toronto Stock Exchange: CTI;), a biotechnology company developing peptide-based therapies to treat cancer, blood disorders, cardiovascular and infectious disease, announced that today it placed 5,471,698 common shares (the "Shares") with a group of primarily institutional investors at a price of CDN$1.06 per Share for gross proceeds of CDN$5.8 million.

Vancouver, BC, October 27, 2005--Forbes Medi-Tech Inc. announced it has completed a US$6 million Private Placement, resulting in the issuance of Series B Convertible Preferred Shares with warrants. The preferred shares are convertible at any time, without further consideration, at the option of the holder at a rate of US$1.65 per common share into a total of 3,636,363 common shares, subject to adjustment.

$4.7 Million of Debt Eliminated and Working Capital Increased by $3.2 Million

Vancouver, BC, April 4, 2005-Westport Innovations Inc. today announced that it and a consortium of partners led by Sacre-Davey Innovations Inc., have been awarded approximately $6 million by the Government of Canada to develop and demonstrate hydrogen technology in energy and transportation applications.

This new funding award relates to a previously announced Vancouver-based demonstration of public transit buses fueled with compressed natural gas (CNG) and hydrogen-enriched natural gas known as HCNG. Further details about this project and partners will be disclosed at a later date.

Victoria, BC, February 4, 2005--GenoLogics Life Sciences Software Inc., developer of an open bioinformatics software platform that assists life science and pharmaceutical research laboratories manage, integrate and analyze enormous volumes of scientific data, today announced that it has completed a $5 million (U.S.) round of financing.